Cardinal Health to Acquire AccessClosure 
|
By HospiMedica International staff writers Posted on 20 Apr 2014 |
|
Image: The Mynx Ace vascular closure device (Photo courtesy of AccessClosure).
Cardinal Health (Dublin, OH, USA) has signed an agreement to acquire AccessClosure (Santa Clara, CA, USA), a manufacturer and distributor of extravascular closure devices, for USD 320 million.
Cardinal Health hopes that the purchase will boost its interventional devices segment with the addition of the Mynx polyethylene glycol (PEG) vascular closure devices, biodegradable vascular sealant devices that help physicians to seal the femoral artery using a unique, secure, sealant which dissolves within 30 days, leaving nothing behind but a healed artery. The deal also aligns Cardinal Health with trending market forces and customers' need for value-driven care and comprehensive healthcare solutions in the interventional cardiology area.
“We are excited about this opportunity because it provides a scalable platform – with an outstanding product, strong customer base, cost-effective service model, and seasoned management team,” said Don Casey, CEO of Cardinal Health’s Medical Segment. “Our goal is to become the partner of choice for solutions that improve patient care while reducing the cost and complexity of procedures for hospital systems.”
“We are extremely pleased to join a healthcare solutions company like Cardinal Health which has existing scale and a structure to grow this business more rapidly and meet the needs of our current and future customers,” said Gregory Casciaro, president and CEO of AccessClosure. “With Cardinal Health’s resources and customer relationships, we can now more readily answer market demand for our innovative solutions that improve both the doctor and patient experience.”
Related Links:
Cardinal Health
AccessClosure
Cardinal Health hopes that the purchase will boost its interventional devices segment with the addition of the Mynx polyethylene glycol (PEG) vascular closure devices, biodegradable vascular sealant devices that help physicians to seal the femoral artery using a unique, secure, sealant which dissolves within 30 days, leaving nothing behind but a healed artery. The deal also aligns Cardinal Health with trending market forces and customers' need for value-driven care and comprehensive healthcare solutions in the interventional cardiology area.
“We are excited about this opportunity because it provides a scalable platform – with an outstanding product, strong customer base, cost-effective service model, and seasoned management team,” said Don Casey, CEO of Cardinal Health’s Medical Segment. “Our goal is to become the partner of choice for solutions that improve patient care while reducing the cost and complexity of procedures for hospital systems.”
“We are extremely pleased to join a healthcare solutions company like Cardinal Health which has existing scale and a structure to grow this business more rapidly and meet the needs of our current and future customers,” said Gregory Casciaro, president and CEO of AccessClosure. “With Cardinal Health’s resources and customer relationships, we can now more readily answer market demand for our innovative solutions that improve both the doctor and patient experience.”
Related Links:
Cardinal Health
AccessClosure
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gas Analyzer
GE SAM
Syringe Pump
SP50 Series
Latest Business News
- Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
- Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
- Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
- Partnership Advances AI Tool for Predicting Malignant Cerebral Edema
- First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
- Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
- FDA Approval Clears Path for BCI Integration with Personal Computing Devices
- Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
- Smart Hospital Market Set for Strong Growth as Digital Healthcare Adoption Accelerates
- FDA Seeks Feedback on Regulating Generative AI Medical Devices
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
- Danaher Completes Acquisition of Masimo to Expand Patient Monitoring Capabilities
- Endologix Adds FDA-Cleared Peripheral Thrombectomy System
Channels
Artificial Intelligence
view channel
AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment
Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more
AI-Powered ECG Model Gains FDA Authorization for Emergency Cardiac Assessment
Powerful Medical’s PMcardio Queen of Hearts (ACS AI ECG Model) has received U.S. Food and Drug Administration (FDA) De Novo authorization, announced on September 15, 2026. The model is designed to identify... Read more
Critical Care
view channel
Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible
Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more
New Sensor Could Bring Contactless Vital Sign Monitoring to Hospital Bedsides
Continuous, non-contact vital sign monitoring could improve patient comfort and reduce infection risk by eliminating electrodes and cables that complicate nursing care and hygiene. However, camera-based... Read more
Surgical Techniques
view channel
Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses
Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more
FDA Approves First Sirolimus Drug-Eluting Balloon for Coronary In-Stent Restenosis
Coronary in-stent restenosis (ISR) accounts for about 10% of the nearly one million percutaneous coronary interventions performed annually in the United States. Treating recurrent narrowing without another... Read more
Patient Care
view channel
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read more
Virtual Reality Helps Claustrophobic Patients Complete Cardiac PET/CT Scans
Anxiety and claustrophobia—intense fear of confined spaces—often prevent patients from completing cardiac positron emission tomography/computed tomography (PET/CT). Aborted scans delay diagnosis, consume... Read more
Medical Imaging
view channel
AI Tool Integrates MRI and Ultrasound to Detect Endometriosis
Endometriosis is a chronic condition in which tissue similar to the uterine lining grows outside the uterus, causing pain, heavy bleeding, and infertility. Diagnosis often depends on surgical visualization,... Read more
New MRI Index Reveals How Brain Blood Flow Supports Cellular Energy Needs
The human brain has minimal energy reserves and relies on tightly regulated blood flow to meet its high metabolic demands. However, clinicians have lacked noninvasive tools to assess how cortical perfusion... Read more
Health IT
view channel
New Tablet Platform Extends Stroke Neurorehabilitation Beyond the Clinic
Continuity and intensity of neurorehabilitation after stroke are critical for functional recovery, but access to ongoing therapy at home often remains limited. Hospitals and outpatient programs therefore... Read more
Smartphone App Improves Blood Pressure Control in Hypertension
Hypertension, or high blood pressure, is a major modifiable driver of cardiovascular, renal, and cerebrovascular morbidity. Despite effective therapies, many adults fail to achieve control, leading to... Read more
Point of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
